Use of diesters of muramyl peptides in oral form as...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/39 (2006.01) A61K 38/14 (2006.01)

Patent

CA 2181899

The invention relates to an externally active immunostimulating pharmaceutical composition characterized in that it contains a diester having the general formula (I) wherein R is CH3, X is L-Ala or L-Thr, R1 is a hydrocarbonaceous group having from 1 to 4 carbon atoms, R2 is a hydrocarbonaceous group having 1 or 2 carbon atoms, in an externally administered formulation compatible with an administration of active principle comprised between 0.1 mg and 5 mg par kg of weight to human beings or animals.

L'invention concerne une composition pharmaceutique immunostimulante active par voie externe, caractérisée en ce qu'elle contient un diester de formule générale (I) dans laquelle: R est CH3, X est L-Ala ou L- Thr, R1 est un groupe hydrocarboné possédant de 1 à 4 atomes de carbone, R2 est un groupe hydrocarboné possédant 1 à 2 atomes de carbone, dans une formulation d'administration par voie externe compatible avec une administration de principe actif comprise entre 0,1 mg et 5 mg par kg de poids chez l'homme ou l'animal.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of diesters of muramyl peptides in oral form as... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of diesters of muramyl peptides in oral form as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of diesters of muramyl peptides in oral form as... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1697283

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.